Semiconductor test equipment maker Teradyne announced its results for the third quarter of 2026 (July–September) on October 27, 2026. Revenue rose 70% from a year earlier to $1.306 billion, and quarterly revenue hit record highs in memory test and integrated system test. Total company revenue, however, came in below the $1.329 billion record set in the April–June quarter. The midpoint of the company's October–December guidance is also $1.3 billion, which suggests recent revenue has been flat at around that level. The 70% year-over-year growth rate obscures this, but the quarter-by-quarter trend suggests that revenue, which had been expanding rapidly, may have reached a plateau.
Results beat market expectations, but shares fell 6% in after-hours trading
According to Teradyne's announcement, revenue for the July–September quarter was $1.306 billion, and non-GAAP diluted earnings per share (EPS) were $2.29. By segment, Semiconductor Test generated $1.072 billion, Product Test $138 million, and Robotics $96 million. CEO Greg Smith explained that AI-related demand is broadening across a wide range of areas, from memory and hard disk drive (HDD) testing to high-speed interconnects and robotics. He said this demand pushed revenue above the high end of the guidance the company had given in advance.
According to analysis by the market information site MoveSurge, prior market expectations were for revenue of $1.26 billion and non-GAAP EPS of $2.04, and actual results beat both. Even so, the stock fell immediately after the release. In trading data recorded by the site, Teradyne shares dropped 6.25% in the 10 minutes after the earnings release went out at 4:30 p.m. Eastern Time on October 27. Volume over that period was 87,149 shares.
This was, however, a brief move in after-hours trading following the regular session, not the closing price on the next trading day. MoveSurge's analysis also does not identify the cause of the decline. Based on the information currently available, it is not possible to determine why the stock fell despite results that beat expectations. So, setting the share price movement aside, we look at changes in revenue and margins from the earnings figures.
Up 70% year over year, but quarterly revenue is flat at around $1.3 billion
Teradyne's revenue for April–June 2026 was $1.329 billion, while July–September came in at $1.306 billion, a decline of about 1.7% from the previous quarter. In addition, the revenue outlook for October–December is $1.25 billion to $1.35 billion, with a midpoint of $1.3 billion. That is about 0.5% below the July–September actual. At least at the midpoint of the company's outlook, a renewed sharp rise in recent revenue is not anticipated.
| Quarter | Revenue | Change from prior quarter |
|---|---|---|
| Jan–Mar 2026 (actual) | $1.282 billion | — |
| Apr–Jun 2026 (actual) | $1.329 billion | +3.6% |
| Jul–Sep 2026 (actual) | $1.306 billion | −1.7% |
| Oct–Dec 2026 (guidance midpoint) | $1.3 billion | −0.5% |
Note that the $1.3 billion for October–December is the midpoint calculated from the high and low ends of the company's published revenue outlook, not a forecast of a specific landing figure. If the company reaches the top of the range, $1.35 billion, that would be an increase of about 3.4% from July–September. Teradyne had also forecast July–September revenue of $1.2 billion to $1.3 billion in its previous quarterly earnings release on July 28. Because the top of that range was below the April–June actual, the possibility of a quarter-on-quarter revenue decline was already built into the company's outlook as of July.
So how should the 70% year-over-year growth rate be interpreted? Revenue in July–September 2025, the comparison base, was $769 million, so this quarter's $1.306 billion is about 1.7 times that. Meanwhile, cumulative revenue for January–September 2026 was $3.917 billion, up 86% from $2.107 billion a year earlier. In other words, growth remains extremely high on a nine-month cumulative basis, but looking at the latest quarter alone, the year-over-year growth rate is below the cumulative figure.
Subtracting the July–September revenue from the nine-month total and comparing only the first half makes the difference clearer. Revenue for January–June 2026 was about $2.611 billion, up about 95% from about $1.337 billion a year earlier. By contrast, year-over-year growth for July–September was only 70%. However, this cannot be taken as clear evidence that demand momentum has weakened. Revenue in July–September 2025 was above the quarterly average of the first half of that year, so the comparison bases are at different levels.
In fact, the $1.306 billion in July–September 2026 is almost identical to the quarterly average of about $1.306 billion for the first half of the year. Rather than the decline in year-over-year growth from 95% to 70%, what deserves attention is that revenue over the last three quarters has hovered around $1.3 billion. Year-over-year, rapid growth is being maintained, but quarter-on-quarter, revenue expansion has paused for now. The two are not contradictory; they capture performance over different time horizons.
Teradyne did, once again, deliver results above its own outlook. July–September revenue of $1.306 billion exceeded the top of its prior guidance, $1.3 billion, by about 0.5%, and the midpoint, $1.25 billion, by about 4.5%. Non-GAAP EPS of $2.29 also topped the high end of guidance, $2.15, by about 6.5%. Flat recent revenue and continued outperformance against the company's forecasts therefore need to be assessed separately.
Margins, meanwhile, show a clearer quarter-on-quarter decline than revenue does. Non-GAAP EPS fell from $2.47 in April–June to $2.29 in July–September, and the non-GAAP operating margin dropped 2.1 points, from 33.7% to 31.6%. The GAAP gross margin also slipped 0.7 points, from 59.8% to 59.1%. While revenue fell 1.7%, selling and administrative expenses rose from $192.5 million to $199 million, and R&D expenses rose from $156.3 million to $163.1 million. Rising costs against flat revenue are pushing down the operating margin.
A pause in growth, or preparation for the next expansion?
There is a credible counterargument to the view that recent revenue is hovering around $1.3 billion. The current flat trend may not indicate a limit to demand; rather, because the company sets its guidance conservatively, future growth may not be fully reflected in the numbers. Several factors support this view.
First, Teradyne has exceeded the top of its advance revenue guidance for two consecutive quarters, April–June and July–September. If this pattern continues, October–December results could also exceed the $1.3 billion midpoint. Second, the October–December guidance is above market expectations. Against the market revenue forecast of $1.26 billion cited by MoveSurge, the company's midpoint of $1.3 billion is about 3% higher. For non-GAAP EPS as well, the midpoint of $2.10 exceeds the market expectation of $2.01. Market expectations vary by data provider, however, so these figures are comparisons against the forecasts MoveSurge published.
The third factor is the rise in inventory. Teradyne's inventory at the end of September 2026 was about $575 million, up about 51% from about $379.6 million at the end of December 2025. The cash flow statement included in this earnings release also shows a cash outflow of $170.9 million for inventory increases in July–September. This can be interpreted as stocking up in preparation for higher shipments. If the company is securing products and components to meet expanding demand, the current flat revenue could prove temporary.
Fourth, management has expressed a positive outlook on growth opportunities from 2027 onward. At the April–June earnings announcement, CEO Smith said investment in front-end semiconductor manufacturing equipment is increasing rapidly and that it would support growth from 2027 onward. If chipmakers' capital spending expands, demand for the test equipment used to inspect the chips they produce could also rise, with a time lag. Even if current revenue is flat, there is some basis for the view that preparations for future demand growth are under way.
Still, these factors alone do not guarantee a reacceleration of growth. While higher inventory may indicate that shipment preparations are advancing, it could also lead to excess stock and write-downs if actual demand falls short of plans. And the fact that the guidance midpoint is above market expectations is not inconsistent with revenue hovering around $1.3 billion. Even if greater investment in chip manufacturing equipment leads to future demand for test equipment, the timing and the contribution to revenue have not been determined.
This analysis therefore does not conclude that Teradyne's medium- to long-term growth has stopped. What can be confirmed at this point is that revenue, which reached $1.329 billion in April–June 2026, edged down in July–September, and the midpoint of the company's October–December outlook stays at a similar level. From this trend, it appears that revenue, which had been expanding rapidly, has entered a short-term plateau.
There are two conditions under which this assessment should be revisited. One is if actual October–December 2026 results exceed the top of the company's outlook, $1.35 billion. The other is if the revenue guidance for January–March 2027, to be given at the next earnings release, is above the same $1.35 billion. If either occurs, it would raise the likelihood that the recent revenue dip was temporary and that growth is reaccelerating. That judgment, however, would also require checking the actual trajectory of revenue and margins.
For Japan's semiconductor industry, the results of competitor Advantest will also be an important point of comparison. According to its official IR calendar, its fiscal 2026 second-quarter results are scheduled to be announced at 3:30 p.m. Japan time on October 28. They will show whether demand for AI semiconductor test equipment remains as high as at Teradyne, or whether differences emerge by customer and product area.
Teradyne's latest results showed that growing AI-related investment is delivering substantial growth to the semiconductor test equipment market. At the same time, the quarter-on-quarter revenue decline and lower margins are changes that the high year-over-year growth rate alone makes hard to see. The focus going forward is whether revenue of around $1.3 billion is only a temporary stall or will persist until the next growth phase begins. Whether October–December results exceed $1.35 billion will be the first key indicator.